The increasing frequencies of Bmi-1 intensive expression in normal ovarian epithelium (0), to benign cystadenomas (3%), to borderline tumors (10%), and to invasive carcinomas were significant (37%, P < 0.05, Table 2). The gene discussed is BMI1; the disease is cystadenoma.